Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
The therapeutic and preventive activities of retinoids in cancer are due to their ability to modulate the growth, differentiation, and survival or apoptosis of cancer cells. Here we show that in NB4 acute promyelocytic leukemia cells, retinoids selective for retinoic-acid receptor-alpha induced an autoregulatory circuitry of survival programs followed by expression of the membrane-bound tumor-selective death ligand, TRAIL (tumor necrosis factor-related apoptosis-inducing ligand, also called Apo-2L). In a paracrine mode of action, TRAIL killed NB4 as well as heterologous and retinoic-acid-resistant cells. In the leukemic blasts of freshly diagnosed acute promyelocytic leukemia patients, retinoic-acid-induced expression of TRAIL most likely caused blast apoptosis. Thus, induction of TRAIL-mediated death signaling appears to contribute to the therapeutic value of retinoids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
International Agency for Research on Cancer
National Cancer Institute (2020) · Definitions · doi:10.32388/pfg7jq · Cited by 9,435
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Wang, C.-Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., & Baldwin, A. S. (1998) · Science · doi:10.1126/science.281.5383.1680 · Cited by 2,711
IAP family proteins---suppressors of apoptosis
Deveraux, Q. L., & Reed, J. C. (1999) · Genes & Development · doi:10.1101/gad.13.3.239 · Cited by 2,551
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.
Walczak, H., Miller, R. E., Ariail, K., Gliniak, B., Griffith, T. S., Kubin, M., Chin, W., Jones, J., Woodward, A., Le, T., et al. (1999) · Nature Medicine · doi:10.1038/5517 · Cited by 2,497
Safety and antitumor activity of recombinant soluble Apo2 ligand
Ashkenazi, A., Pai, R. C., Fong, S., Leung, S., Lawrence, D. A., Marsters, S. A., Blackie, C., Chang, L., McMurtrey, A. E., Hebert, A., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6926 · Cited by 2,213
The Receptor for the Cytotoxic Ligand TRAIL
Pan, G., O'Rourke, K., Chinnaiyan, A. M., Gentz, R., Ebner, R., Ni, J., & Dixit, V. M. (1997) · Science · doi:10.1126/science.276.5309.111 · Cited by 1,767
Programmed Cell Death and the Control of Cell Survival: Lessons from the Nervous System
Raff, M. C., Barres, B. A., Burne, J. F., Coles, H. S., Ishizaki, Y., & Jacobson, M. D. (1993) · Science · doi:10.1126/science.8235590 · Cited by 1,460
Apoptosis control by death and decoy receptors
Ashkenazi, A., & Dixit, V. M. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80034-9 · Cited by 1,288
The retinoids—Biology, chemistry and medicine
(1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)80793-5 · Cited by 1,178
Cited by
Targeting death and decoy receptors of the tumour-necrosis factor superfamily
Ashkenazi, A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc821 · Cited by 1,360
Targeting Apoptosis Pathways in Cancer Therapy
Ghobrial, I. M., Witzig, T. E., & Adjei, A. A. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.3.178 · Cited by 1,330
Principles for modulation of the nuclear receptor superfamily
Gronemeyer, H., Gustafsson, J.-Å., & Laudet, V. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1551 · Cited by 1,226
Self-citationReactive oxygen species and cancer paradox: To promote or to suppress?
Galadari, S., Rahman, A., Pallichankandy, S., & Thayyullathil, F. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.004 · Cited by 893
The promise of retinoids to fight against cancer
Altucci, L., & Gronemeyer, H. (2001) · Nature Reviews Cancer · doi:10.1038/35106036 · Cited by 773
Self-citationPediatric acute lymphoblastic leukemia
Inaba, H., & Mullighan, C. G. (2020) · Haematologica · doi:10.3324/haematol.2020.247031 · Cited by 696
Schug, T. T., Berry, D. C., Shaw, N. S., Travis, S. N., & Noy, N. (2007) · Cell · doi:10.1016/j.cell.2007.02.050 · Cited by 680
Schenk, T., Chen, W. C., Göllner, S., Howell, L., Jin, L., Hebestreit, K., Klein, H.-U., Popescu, A. C., Burnett, A., Mills, K., et al. (2012) · Nature Medicine · doi:10.1038/nm.2661 · Cited by 672
Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells
Nebbioso, A., Clarke, N., Voltz, E., Germain, E., Ambrosino, C., Bontempo, P., Alvarez, R., Schiavone, E. M., Ferrara, F., Bresciani, F., et al. (2005) · Nature Medicine · doi:10.1038/nm1161 · Cited by 610
Self-citationExploring the TRAILs less travelled: TRAIL in cancer biology and therapy
von Karstedt, S., Montinaro, A., & Walczak, H. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.28 · Cited by 556
RAR and RXR modulation in cancer and metabolic disease
Altucci, L., Leibowitz, M. D., Ogilvie, K. M., de Lera, A. R., & Gronemeyer, H. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2397 · Cited by 517
Self-citationApoptosis-targeted therapies for cancer
Reed, J. C. (2003) · Cancer Cell · doi:10.1016/s1535-6108(02)00241-6 · Cited by 500
Retinoic acid receptors: From molecular mechanisms to cancer therapy
di Masi, A., Leboffe, L., De Marinis, E., Pagano, F., Cicconi, L., Rochette-Egly, C., Lo-Coco, F., Ascenzi, P., & Nervi, C. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.12.003 · Cited by 403
International Union of Pharmacology. LX. Retinoic Acid Receptors
Germain, P., Chambon, P., Eichele, G., Evans, R. M., Lazar, M. A., Leid, M., De Lera, A. R., Lotan, R., Mangelsdorf, D. J., & Gronemeyer, H. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.4.4 · Cited by 397
Self-citationRetinoids regulate stem cell differentiation
Gudas, L. J., & Wagner, J. A. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22417 · Cited by 395
“Retinoids can increase the expression of TRAIL receptors and decrease expression of TRAIL decoy receptors in cancer cells (e.g., Sun et al., 2000; Altucci et al., 2001).”
BackgroundHow acute promyelocytic leukaemia revived arsenic
Zhu, J., Chen, Z., Lallemand-Breitenbach, V., & de Thé, H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc887 · Cited by 321
Zamai, L., Ponti, C., Mirandola, P., Gobbi, G., Papa, S., Galeotti, L., Cocco, L., & Vitale, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4011 · Cited by 292
Targeting Apoptosis Pathways in Cancer Therapy
Fulda, S., & Debatin, K.-M. (2004) · Current Cancer Drug Targets · doi:10.2174/1568009043332763 · Cited by 290
Death Receptor Regulation and Celecoxib-Induced Apoptosis in Human Lung Cancer Cells
Liu, X., Yue, P., Zhou, Z., Khuri, F. R., & Sun, S.-Y. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh322 · Cited by 265
Functions, Therapeutic Applications, and Synthesis of Retinoids and Carotenoids
Álvarez, R., Vaz, B., Gronemeyer, H., & de Lera, Á. R. (2014) · Chemical Reviews · doi:10.1021/cr400126u · Cited by 260
Self-citationTRAIL and its receptors as targets for cancer therapy
Yagita, H., Takeda, K., Hayakawa, Y., Smyth, M. J., & Okumura, K. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb02181.x · Cited by 254
Developing TRAIL/TRAIL death receptor-based cancer therapies
Yuan, X., Gajan, A., Chu, Q., Xiong, H., Wu, K., & Wu, G. S. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9728-y · Cited by 248
Endometriosis and nuclear receptors
Yilmaz, B. D., & Bulun, S. E. (2019) · Human Reproduction Update · doi:10.1093/humupd/dmz005 · Cited by 243
Nuclear receptor PXR, transcriptional circuits and metabolic relevance
Ihunnah, C. A., Jiang, M., & Xie, W. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.01.014 · Cited by 225
TRAIL promotes metastasis of human pancreatic ductal adenocarcinoma
Trauzold, A., Siegmund, D., Schniewind, B., Sipos, B., Egberts, J., Zorenkov, D., Emme, D., Röder, C., Kalthoff, H., & Wajant, H. (2006) · Oncogene · doi:10.1038/sj.onc.1209719 · Cited by 219
All Trans Retinoic Acid and Cancer
Siddikuzzaman, Guruvayoorappan, C., & Berlin Grace, V. M. (2011) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2010.521507 · Cited by 209
Translocations of the RARα gene in acute promyelocytic leukemia
Zelent, A., Guidez, F., Melnick, A., Waxman, S., & Licht, J. D. (2001) · Oncogene · doi:10.1038/sj.onc.1204766 · Cited by 207
Pediatric Acute Lymphoblastic Leukemia
Carroll, W. L., Bhojwani, D., Min, D.-J., Raetz, E. A., Relling, M. V., Davies, S. M., Downing, J. R., Willman, C. L., & Reed, J. C. (2003) · Hematology · doi:10.1182/asheducation-2003.1.102 · Cited by 199
Between Death and Survival: Retinoic Acid in Regulation of Apoptosis
Noy, N. (2010) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.28.061807.155509 · Cited by 193
BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect
Hallahan, A. R., Pritchard, J. I., Chandraratna, R. A. S., Ellenbogen, R. G., Geyer, J. R., Overland, R. P., Strand, A. D., Tapscott, S. J., & Olson, J. M. (2003) · Nature Medicine · doi:10.1038/nm904 · Cited by 192
Mai, A., Massa, S., Pezzi, R., Simeoni, S., Rotili, D., Nebbioso, A., Scognamiglio, A., Altucci, L., Loidl, P., & Brosch, G. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049002a · Cited by 184
Self-citationDiverse actions of retinoid receptors in cancer prevention and treatment
Mongan, N. P., & Gudas, L. J. (2007) · Differentiation · doi:10.1111/j.1432-0436.2007.00206.x · Cited by 182
Drug Insight: cancer therapy strategies based on restoration of endogenous cell death mechanisms
Reed, J. C. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0538 · Cited by 179
Dysregulation of apoptosis genes in hematopoietic malignancies
Kitada, S., Pedersen, I. M., Schimmer, A. D., & Reed, J. C. (2002) · Oncogene · doi:10.1038/sj.onc.1205327 · Cited by 176
mTOR Controls FLIPS Translation and TRAIL Sensitivity in Glioblastoma Multiforme Cells
Panner, A., James, C. D., Berger, M. S., & Pieper, R. O. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.20.8809-8823.2005 · Cited by 154
Martelli, A. M., Tazzari, P. L., Tabellini, G., Bortul, R., Billi, A. M., Manzoli, L., Ruggeri, A., Conte, R., & Cocco, L. (2003) · Leukemia · doi:10.1038/sj.leu.2403044 · Cited by 172
Deregulation of apoptosis in acute myeloid leukemia
Testa, U., & Riccioni, R. (2007) · Haematologica · doi:10.3324/haematol.10279 · Cited by 171
Mai, A., Valente, S., Meade, S., Carafa, V., Tardugno, M., Nebbioso, A., Galmozzi, A., Mitro, N., De Fabiani, E., Altucci, L., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9008289 · Cited by 156
Self-citationMistry, A. R., Pedersen, E. W., Solomon, E., & Grimwade, D. (2003) · Blood Reviews · doi:10.1016/s0268-960x(02)00075-9 · Cited by 168
TRAIL as a target in anti-cancer therapy
Wu, G. S. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.029 · Cited by 168
Zhu, J., Lallemand-Breitenbach, V., & de Thé, H. (2001) · Oncogene · doi:10.1038/sj.onc.1204852 · Cited by 164
Zhou, G., Zhang, J., Wang, Z., Chen, S., & Chen, Z. (2007) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2007.2026 · Cited by 164
Wajant, H., Pfizenmaier, K., & Scheurich, P. (2002) · APOPTOSIS · doi:10.1023/a:1020039225764 · Cited by 163
Kitahara, O., Katagiri, T., Tsunoda, T., Harima, Y., & Nakamura, Y. (2002) · Neoplasia · doi:10.1038/sj.neo.7900251 · Cited by 163
Tumor suppressor IRF‐1 mediates retinoid and interferon anticancer signaling to death ligand TRAIL
Clarke, N., Jimenez-Lara, A. M., Voltz, E., & Gronemeyer, H. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600302 · Cited by 163
Self-citationCROSAS, B., HYNDMAN, D. J., GALLEGO, O., MARTRAS, S., PARÉS, X., FLYNN, T. G., & FARRÉS, J. (2003) · Biochemical Journal · doi:10.1042/bj20021818 · Cited by 162
Raffoux, E., Rousselot, P., Poupon, J., Daniel, M.-T., Cassinat, B., Delarue, R., Taksin, A.-L., Réa, D., Buzyn, A., Tibi, A., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.149 · Cited by 152
Self-citationRetinoic acid resistance in acute promyelocytic leukemia
Gallagher, R. (2002) · Leukemia · doi:10.1038/sj.leu.2402719 · Cited by 157
Dimberg, A., Bahram, F., Karlberg, I., Larsson, L.-G., Nilsson, K., & Öberg, F. (2002) · Blood · doi:10.1182/blood.v99.6.2199 · Cited by 142
Mai, A., Rotili, D., Tarantino, D., Ornaghi, P., Tosi, F., Vicidomini, C., Sbardella, G., Nebbioso, A., Miceli, M., Altucci, L., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060601m · Cited by 144
Self-citationMelnik, B. C. (2017) · Acta Dermato Venereologica · doi:10.2340/00015555-2535 · Cited by 153
Mai, A., Cheng, D., Bedford, M. T., Valente, S., Nebbioso, A., Perrone, A., Brosch, G., Sbardella, G., De Bellis, F., Miceli, M., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701595q · Cited by 135
Self-citationTumor therapeutics by design: targeting and activation of death receptors
Wajant, H., Gerspach, J., & Pfizenmaier, K. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.12.001 · Cited by 148
Nuclear receptors in cell life and death
Altucci, L., & Gronemeyer, H. (2001) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00502-1 · Cited by 144
Self-citationTowards novel paradigms for cancer therapy
Pavet, V., Portal, M. M., Moulin, J.-F., Herbrecht, R., & Gronemeyer, H. (2010) · Oncogene · doi:10.1038/onc.2010.460 · Cited by 143
Self-citationChemoprevention of colorectal cancer by targeting APC-deficient cells for apoptosis
Zhang, L., Ren, X., Alt, E., Bai, X., Huang, S., Xu, Z., Lynch, P. M., Moyer, M. P., Wen, X.-F., & Wu, X. (2010) · Nature · doi:10.1038/nature08871 · Cited by 141
LncRNAs: New Players in Apoptosis Control
Rossi, M. N., & Antonangeli, F. (2014) · International Journal of Cell Biology · doi:10.1155/2014/473857 · Cited by 142
1,3,4-Oxadiazole-Containing Histone Deacetylase Inhibitors: Anticancer Activities in Cancer Cells
Valente, S., Trisciuoglio, D., Luca, T. D., Nebbioso, A., Labella, D., Lenoci, A., Bigogno, C., Dondio, G. M., Miceli, M., Brosch, G., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500303u · Cited by 141
Self-citationBontempo, P., Mita, L., Miceli, M., Doto, A., Nebbioso, A., Bellis, F. D., Conte, M., Minichiello, A., Manzo, F., Carafa, V., et al. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.05.010 · Cited by 141
Self-citationAnticancer drugs of tomorrow: apoptotic pathways as targets for drug design
Łoś, M., Burek, C. J., Stroh, C., Benedyk, K., Hug, H., & Mackiewicz, A. A. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02563-1 · Cited by 136
Body language: the function of PML nuclear bodies in apoptosis regulation
Hofmann, T. G., & Will, H. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401313 · Cited by 136
Receptor- and mitochondrial-mediated apoptosis in acute leukemia: a translational view
Schimmer, A. D., Hedley, D. W., Penn, L. Z., & Minden, M. D. (2001) · Blood · doi:10.1182/blood.v98.13.3541 · Cited by 135
Retinoids: potential in cancer prevention and therapy
Clarke, N., Germain, P., Altucci, L., & Gronemeyer, H. (2004) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399404008488 · Cited by 115
Self-citationTRAIL decoy receptors mediate resistance of acute myeloid leukemia cells to TRAIL.
Riccioni, R., Pasquini, L., Mariani, G., Saulle, E., Rossini, A., Diverio, D., Pelosi, E., Vitale, A., Chierichini, A., Cedrone, M., et al. (2005) · PubMed · Cited by 132
Donato, L. J., Suh, J. H., & Noy, N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-0989 · Cited by 118
Altucci, L., Rossin, A., Hirsch, O., Nebbioso, A., Vitoux, D., Wilhelm, E., Guidez, F., De Simone, M., Schiavone, E. M., Grimwade, D., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3569 · Cited by 114
Self-citationDonato, L. J., & Noy, N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1177 · Cited by 123
Multivalent DR5 Peptides Activate the TRAIL Death Pathway and Exert Tumoricidal Activity
Pavet, V., Beyrath, J., Pardin, C., Morizot, A., Lechner, M., Briand, J., Wendland, M., Maison, W., Fournel, S., Micheau, O., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2889 · Cited by 121
Self-citationRottmann, S., Wang, Y., Nasoff, M., Deveraux, Q. L., & Quon, K. C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505114102 · Cited by 107
Kitareewan, S., Pitha-Rowe, I., Sekula, D., Lowrey, C. H., Nemeth, M. J., Golub, T. R., Freemantle, S. J., & Dmitrovsky, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052011299 · Cited by 117
Zhao, H., Zhang, X., Frazão, J. B., Condino‐Neto, A., & Newburger, P. E. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24586 · Cited by 111
Yang, X., Merchant, M. S., Romero, M. E., Tsokos, M., Wexler, L. H., Kontny, U., Mackall, C. L., & Thiele, C. J. (2003) · PubMed · Cited by 111
TNF‐related apoptosis‐inducing ligand as a therapeutic agent in autoimmunity and cancer
Cretney, E., Shanker, A., Yagita∥, H., Smyth, M. J., & Sayers, T. J. (2006) · Immunology and Cell Biology · doi:10.1111/j.1440-1711.2005.01413.x · Cited by 109
Initiation factor modifications in the preapoptotic phase
Morley, S., Coldwell, M. J., & Clemens, M. J. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401591 · Cited by 109
Modulating apoptosis as a target for effective therapy
Fleischer, A., Ghadiri, A., Dessauge, F., Duhamel, M., Rebollo, M. P., Alvarez-Franco, F., & Rebollo, A. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2005.07.013 · Cited by 108
Hietakangas, V., Poukkula, M., Heiskanen, K. M., Karvinen, J. T., Sistonen, L., & Eriksson, J. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.4.1278-1291.2003 · Cited by 106
Sayers, T. J., & Murphy, W. J. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0676-3 · Cited by 102
The role of the retinoid receptor, RAR/RXR heterodimer, in liver physiology
Li, B., Cai, S., & Boyer, J. L. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166085 · Cited by 100
Role of nuclear bodies in apoptosis signalling
Krieghoff‐Henning, E., & Hofmann, T. G. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.07.002 · Cited by 100
RA-inducible gene-I induction augments STAT1 activation to inhibit leukemia cell proliferation
Jiang, L., Zhang, N., Ding, F., Li, X.-Y., Chen, L., Zhang, H., Zhang, W., Chen, S., Wang, Z., Li, J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019059108 · Cited by 95
Acute promyelocytic leukemia: where does it stem from?
Grimwade, D. J., & Enver, T. (2004) · Leukemia · doi:10.1038/sj.leu.2403234 · Cited by 94
Park, D. J., Vuong, P. T., de Vos, S., Douer, D., & Koeffler, H. P. (2003) · Blood · doi:10.1182/blood-2003-02-0412 · Cited by 84
Function of RARα during the maturation of neutrophils
Kastner, P., & Chan, S. H. (2001) · Oncogene · doi:10.1038/sj.onc.1204757 · Cited by 94
Secchiero, P., Gonelli, A., Mirandola, P., Melloni, E., Zamai, L., Celeghini, C., Milani, D., & Zauli, G. (2002) · Blood · doi:10.1182/blood-2002-01-0047 · Cited by 92
Antioxidant, antimicrobial and anti-proliferative activities of Solanum tuberosum L. var. Vitelotte
Bontempo, P., Carafa, V., Grassi, R., Basile, A., Tenore, G. C., Formisano, C., Rigano, D., & Altucci, L. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.12.048 · Cited by 91
Self-citationTreatment of Acute Promyelocytic Leukemia with ATRA and As2O3: A Model of Molecular
Fang, J., Chen, S., Tong, J., Wang, Z., & and, G.-Q. C. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.308 · Cited by 88
Structure, function and modulation of retinoic acid receptor beta, a tumor suppressor
Álvarez, S., Germain, P., Álvarez, R., Rodríguez‐Barrios, F., Gronemeyer, H., & de Lera, Á. R. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.02.010 · Cited by 85
Self-citationPsidium guajava L. anti‐neoplastic effects: induction of apoptosis and cell differentiation
Bontempo, P., Doto, A., Miceli, M., Mita, L., Benedetti, R., Nebbioso, A., Veglione, M., Rigano, D., Cioffi, M., Sica, V., et al. (2011) · Cell Proliferation · doi:10.1111/j.1365-2184.2011.00797.x · Cited by 81
Self-citationSakoe, Y., Sakoe, K., Kirito, K., Ozawa, K., & Komatsu, N. (2010) · Blood · doi:10.1182/blood-2009-05-222976 · Cited by 79
Regulation of TRAIL-Induced Apoptosis by Ectopic Expression of Antiapoptotic Factors
Aggarwal, B. B., Bhardwaj, U., & Takada, Y. (2004) · Vitamins and hormones · doi:10.1016/s0083-6729(04)67023-3 · Cited by 78
Potential and caveats of TRAIL in cancer therapy
Held, J., & Schulze‐Osthoff, K. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0208 · Cited by 78
Younes, A., & Aggarwal, B. B. (2003) · Cancer · doi:10.1002/cncr.11524 · Cited by 76
Mohty, M., Morbelli, S. D., Isnardon, D., Sainty, D., Arnoulet, C., Gaugler, B., & Olive, D. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04489.x · Cited by 76
Retinoid target genes in acute promyelocytic leukemia
Pitha, I., Petty, W. J., Kitareewan, S., & Dmitrovsky, E. (2003) · Leukemia · doi:10.1038/sj.leu.2403065 · Cited by 76
Synergy between all-trans retinoic acid and tumor necrosis factor pathways in acute leukemia cells
Witcher, M., Ross, D. T., Rousseau, C., deLuca, L. S., & Miller, W. H. (2003) · Blood · doi:10.1182/blood-2002-09-2725 · Cited by 76
Selective retinoids and rexinoids in cancer therapy and chemoprevention
Zusi, F. C., Lorenzi, M. V., & Vivat, V. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02526-6 · Cited by 75
Borbone, E., Berlingieri, M. T., Bellis, F. D., Nebbioso, A., Chiappetta, G., Mai, A., Altucci, L., & Fusco, A. (2009) · Oncogene · doi:10.1038/onc.2009.306 · Cited by 74
Self-citationAcute Promyelocytic Leukemia: A Paradigm for Differentiation Therapy
Grimwade, D. J., Mistry, A. R., Solomon, E., & Guidez, F. (2009) · Cancer treatment and research · doi:10.1007/978-0-387-69259-3_13 · Cited by 73
Curcumin restores sensitivity to retinoic acid in triple negative breast cancer cells
Thulasiraman, P., McAndrews, D. J., & Mohiuddin, I. Q. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-724 · Cited by 72
Inhibition of IκB Kinase by a New Class of Retinoid-Related Anticancer Agents That Induce Apoptosis
Bayón, Y., Ortiz, M. A., López-Hernández, F. J., Gao, F., Karin, M., Pfahl, M., & Piedrafita, F. J. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.3.1061-1074.2003 · Cited by 71
Metadata
- Authors
- Altucci, L., Rossin, A., Raffelsberger, W., Reitmair, A., Chomienne, C., & Gronemeyer, H.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Hôpital Saint-Louis (FR)
- Corresponding author
- Gronemeyer, Hinrich
- Venue
- Nature Medicine
- Published
- 2001-06
- Volume
- 7
- Issue
- 6
- Pages
- 680-686
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1551972473
- Cited by
- 340
- References
- 47
- Citations by year
- 2025: 2 · 2024: 4 · 2023: 4 · 2022: 3 · 2021: 7 · 2020: 5 · 2019: 8 · 2018: 5 · 2017: 14 · 2016: 6 · 2015: 8 · 2014: 12 · 2013: 9 · 2012: 10
- FWCI
- 11.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- retinoic acid, retinoids, TRAIL, apoptosis, acute promyelocytic leukemia, NB4 cells, retinoic acid receptor alpha, paracrine signaling, retinoic acid resistance, leukemia cell survival
- MeSH terms
- Arsenic Trioxide, Antineoplastic Agents, Arsenicals, Cell Differentiation, Humans, Membrane Glycoproteins, Neoplasm Proteins, Oxides, Proteins, Recombinant Fusion Proteins, Tretinoin, Tumor Cells, Cultured, Tumor Necrosis Factor-alpha, Immunoblotting, Signal Transduction, Leukemia, Promyelocytic, Acute, Oncogene Proteins, Fusion, NF-kappa B, Apoptosis, Receptors, Tumor Necrosis Factor, Coculture Techniques, Paracrine Communication, Caspases, TNF Receptor-Associated Factor 1, Apoptosis Regulatory Proteins, Inhibitor of Apoptosis Proteins, TNF-Related Apoptosis-Inducing Ligand
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.